MedPath

Prevalence of Heterozygote Mothers for Pompe's Disease Among Mothers Having Delivered in French Guiana

Completed
Conditions
Pompe's Disease
Registration Number
NCT02903654
Lead Sponsor
Centre Hospitalier de Cayenne
Brief Summary

Given the high incidence of Pompe's Disease in French Guiana (100 times higher than in mainland France) the aim is to determine the prevalence of heterozygotes among women having just delivered in French Guiana who accepted that their newborn child enters the depipomp1 study. In these women the specific mutations p.Gly648Ser and p.Arg854X will be sought using PCR in order to calculate the prevalence of these mutations and estimate the risk factors associated with them in order to improve genetic counselling.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
925
Inclusion Criteria
  • women having delivered in French Guiana whose child was enroled in the depipomp1 study
Exclusion Criteria
  • refusal to participate

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
prevalence of p.Gly648Ser and p.Arg854XWithin 3 days after birth

number of positive mutations divided by total number of women tested

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.